We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 18288 for:    United Therapeutics cell
Previous Study | Return to List | Next Study

Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension (PAH)

This study has been terminated.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01795950
First Posted: February 21, 2013
Last Update Posted: February 17, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
United Therapeutics
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2016
  Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)